FDA Tackles 3-D Printing Considerations In Draft Guidance
This article was originally published in The Gray Sheet
A draft guidance issued by FDA on additive manufacturing, or 3-D printing, of medical devices is meant to be a starting point for an industry that is growing exponentially. The document outlines recommendations on topics such as device design, software considerations and material testing requirements.
Register for our free email digests: